Natural Steroid Pregnenolone Reduces Amygdala Connectivity in Women With Depression, Early Study Finds

Pregnenolone and brain connectivity in women with depression, Digimart Global: Researchers at UT Southwestern Medical Center, including two colleagues at UT Dallas, report evidence that pregnenolone, a naturally occurring steroid hormone the body produces from cholesterol, may change how key brain regions involved in depression and cognitive control communicate. The study was published in the Journal of Clinical Psychiatry.

The trial followed 29 women with mild to moderate major depressive disorder in a double-blind, placebo-controlled crossover design. Participants received three seven-day treatment conditions: 500 or 800 milligrams per day of pregnenolone taken orally, or placebo.

Brain activity was assessed using functional MRI, which measures changes in blood flow and oxygen levels, alongside serum blood samples. Only 11 participants had usable fMRI data from all three treatments, so the final brain analysis rests on a small group.

Compared with placebo, the 500 mg daily dose reduced functional connectivity between the amygdala and the left frontal pole, regions involved in emotional processing and cognitive control. The researchers say this change may reflect improved emotional regulation, a process often impaired in depression, and may help explain a possible antidepressant effect of pregnenolone and related neurosteroids.

The 800 mg dose did not produce the same connectivity change, suggesting that a higher amount does not necessarily produce a stronger effect on these circuits. Both doses were well tolerated, with no serious adverse events reported, and blood tests showed both significantly increased levels of allopregnanolone, a downstream neurosteroid involved in regulating brain signalling.

The lead corresponding author, E. Sherwood Brown, M.D., Ph.D., M.B.A., Professor of Psychiatry at UT Southwestern, said earlier studies had suggested pregnenolone could help people with bipolar disorder who are depressed, but its effects on brain networks were not well understood.

Contributing author Francesca Filbey, Ph.D., of the UT Dallas Center for BrainHealth, said the work sheds light on how neurosteroids may influence brain connectivity in women with depression, a group she noted has been studied less.

Next steps include determining whether the observed connectivity changes are linked to improvements in depressive symptoms or cognition, and replicating the findings in a larger sample. Dr.

Brown said the aim is to establish whether pregnenolone or related compounds can provide a clinically meaningful treatment option, and that it remains to be seen whether these brain changes translate into meaningful improvements for patients. The study was funded by a grant from the National Center for Complementary and Integrative Health of the National Institutes of Health.

Callum Fletcher

Callum Fletcher covers international news, Australian sports, entertainment, and cultural developments. His reporting focuses on major global events and trending stories relevant to audiences throughout Australia.
Copy Profile

Leave a Reply

Your email address will not be published. Required fields are marked *

Sports

Explore Digimart Global